Clinical Trials Directory

Trials / Completed

CompletedNCT05631119

Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Sanguine Biosciences · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers

Summary

The Investigators will generate a repository of human biosamples across therapeutic areas that will be used to identify disease-associated biomarkers and potential targets with immune and multi-omics profiling. This sample collection and analysis from people living with type 2 diabetes, or chronic or diabetic kidney disease will lay the groundwork for an extensive network of biosample access and linked datasets that will provide an invaluable resource for translational research.

Detailed description

The Investigators will generate a repository of human biosamples across therapeutic areas that will be used to identify disease-associated biomarkers and potential targets with immune and multi-omics profiling. This sample collection and analysis from people living with type 2 diabetes, or chronic or diabetic kidney disease will lay the groundwork for an extensive network of biosample access and linked datasets that will provide an invaluable resource for translational research.

Conditions

Timeline

Start date
2022-12-15
Primary completion
2023-08-23
Completion
2023-08-23
First posted
2022-11-30
Last updated
2023-10-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05631119. Inclusion in this directory is not an endorsement.